CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,066,101 | -80.3% | 195,839 | -76.1% | 0.03% | -82.7% |
| Q2 2022 | $10,494,000 | +111.0% | 818,572 | +72.3% | 0.16% | +100.0% |
| Q1 2022 | $4,974,000 | -32.1% | 475,058 | 0.0% | 0.08% | -22.9% |
| Q4 2021 | $7,330,000 | -31.6% | 475,058 | 0.0% | 0.10% | -40.0% |
| Q3 2021 | $10,722,000 | -25.8% | 475,058 | -15.4% | 0.18% | -34.9% |
| Q2 2021 | $14,451,000 | -36.1% | 561,206 | +3.4% | 0.27% | -46.4% |
| Q1 2021 | $22,623,000 | – | 542,912 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |